Pfizer and BioNTech announced that their Covid vaccine is safe and effective for children aged 5-11. This is overdue relief for many American women
It was the news that parents had been waiting to hear for more than a year and a half: on Monday, Pfizer and BioNTech announced that their Covid-19 vaccine is safe and effective for children aged five to 11. The pediatric dose, administered at one-third the volume of the adult dose, creates a “robust” immune response that is predicted to protect child patients from severe disease and death from Covid. Crucially, the trials, in which the vaccine was administered to 2,268 children, found no cases of myocarditis, an inflammation of the heart that is a very rare but serious side-effect of some mRNA vaccines in adults. The companies are requesting emergency use authorization from the Food and Drug Administration, (FDA) and if the FDA moves at the same pace that it did in granting emergency approval for the adult vaccine, that will mean that vaccinations of school-aged children could begin as early as Halloween – though logistical and political obstacles could still delay the shots.
The announcement is a light at the end of the tunnel for parents, who have seen their children’s lives unfairly warped by the coronavirus pandemic. Schools were closed, activities were shuttered, and opportunities to visit relatives or play with other kids were suddenly fraught with risk. During the long wait for child vaccinations, the commentary on the urgency of vaccine development has rightly focused on the pandemic’s devastating effects on children – medical, educational and developmental.
Read the original article at The Guardian